Pharmaceutical company Novartis has suffered setbacks involving two drugs, according to TimesLIVE, adding pressure on the company's drug development pipeline. The failures also increase scrutiny of chief executive Vas Narasimhan and his mergers-and-acquisitions strategy, which he has pursued to bolster the Swiss drugmaker's growth prospects.
AI summary. Verify with the original source.
Read full story at TimesLIVE ↗
Listen
Unlock audio summaries, audio summaries, AI chat, Wikipedia facts, and ad-free reading.
$3.99 / month · cancel anytime
Go PremiumBackground facts
Unlock wikipedia facts, audio summaries, AI chat, Wikipedia facts, and ad-free reading.
$3.99 / month · cancel anytime
Go PremiumSources
Similar stories

According to Moneyweb, Bukula has resigned from his position as chair of Nersa, the National Energy Regulator of South Africa. Following this development, the minister has called for nominations for the CEO position within the organization.
Moneyweb·June 25, 2026 at 2:07 AM
Datatec CEO Jens Montanana has adjusted the parameters of a 2.4-million-share collar as the company's share price experiences a significant increase. This move reflects the company's positive market performance and aims to optimize shareholder value.
TechCentral·June 25, 2026 at 6:15 AM
Emile Burger is resigning from his position as CEO of Tarsus Distribution after serving for 14 months. The announcement marks a significant leadership change within the company.
TechCentral·July 1, 2026 at 11:23 AM
Kenya's efforts to boost local drug manufacturing are facing challenges due to fiscal and tax unpredictability. Frequent policy shifts and inconsistent incentives are creating uncertainty for investors, which undermines long-term planning for pharmaceutical manufacturers aiming to expand their operations.
Eastleigh Voice·June 24, 2026 at 6:15 PM
Centum Investment Company has announced a leadership change after Chief Executive Officer Dr James Mworia resigned to head the newly established Kenya National Infrastructure Fund, effective 7 September 2026. According to the Centum Board, Thomas Omondi-Achola, the Group's current Chief, will serve as acting CEO. Omondi-Achola is described as a seasoned mathematician and manager. The appointment is in an acting capacity while the firm manages the transition following Mworia's departure to the new state-backed infrastructure fund.
Business Today (KE)·September 7, 2026 at 9:07 AM
Moneyweb interviewed Makwe Masilela of Makwe Fund Managers about markets struggling to find direction at the end of the US earnings season. The discussion covered JSE performance, commodities and resources, China’s weaker-than-expected GDP, the US debt ceiling, share buybacks and Brent crude rising above $90 a barrel amid heightened Gulf tensions, according to the Moneyweb item.
Moneyweb·September 7, 2026 at 5:40 PM